Molecule.one Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1M
- Investors
-
16
Molecule.one General Information
Description
Developer of an artificial intelligence platform designed for autonomous drug discovery. The company offers an artificial intelligence platform that combines frontier chemistry models with high-throughput experimentation and proprietary data, enabling pharmaceutical researchers to automate synthesis planning, predict reaction outcomes, and discover new chemical reactions for drug manufacturing.
Contact Information
Website
www.molecule.oneCorporate Office
- 4370 Alpine Road
- Suite 104
- Portola Valley, CA 94028
- United States
Corporate Office
- 4370 Alpine Road
- Suite 104
- Portola Valley, CA 94028
- United States
Molecule.one Timeline
Molecule.one Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 11-Jun-2025 | $1M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 04-May-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 23-Oct-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 07-Aug-2019 | $58.9K | $58.9K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Molecule.one Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 490,572 | $0.000100 | $0.17 | $0.17 | 1x | $0.17 | 3.97% | |
| Seed-1 | 471,715 | $0.000100 | $0.18 | $0.18 | 1x | $0.18 | 3.81% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Molecule.one Comparisons
Industry
Financing
Details
Molecule.one Competitors (14)
One of Molecule.one’s 14 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA | ||||
| Chemical Computing Group | Private Equity-Backed | Montreal, Canada | ||||
| X-37 | Venture Capital-Backed | South San Francisco, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| NuMedii | Formerly VC-backed | San Mateo, CA |
Molecule.one Patents
Molecule.one Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025215117-A1 | Systems for chemistry tasks based on artificial intelligence methods with improved reasoning using chemistry feedback | Pending | 10-Apr-2024 | ||
| CA-3235430-A1 | Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset | Pending | 22-Oct-2021 | ||
| EP-4420131-A1 | Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset | Pending | 22-Oct-2021 | ||
| US-20230131234-A1 | Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset | Pending | 22-Oct-2021 | ||
| WO-2023067202-A1 | Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset | Inactive | 22-Oct-2021 | G16C20/10 |
Molecule.one Signals
Molecule.one Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Standard Industries | Corporation | |||
| ff Venture Capital | Venture Capital | Minority | ||
| HNVR Technology Investment Management | Venture Capital | Minority | ||
| AME Cloud Ventures | Venture Capital | Minority | ||
| Atmos Ventures | Venture Capital | Minority |
Molecule.one FAQs
-
When was Molecule.one founded?
Molecule.one was founded in 2016.
-
Where is Molecule.one headquartered?
Molecule.one is headquartered in Portola Valley, CA.
-
What is the size of Molecule.one?
Molecule.one has 37 total employees.
-
What industry is Molecule.one in?
Molecule.one’s primary industry is Discovery Tools (Healthcare).
-
Is Molecule.one a private or public company?
Molecule.one is a Private company.
-
What is Molecule.one’s current revenue?
The current revenue for Molecule.one is .
-
How much funding has Molecule.one raised over time?
Molecule.one has raised $4.68M.
-
Who are Molecule.one’s investors?
Standard Industries, ff Venture Capital, HNVR Technology Investment Management, AME Cloud Ventures, and Atmos Ventures are 5 of 16 investors who have invested in Molecule.one.
-
Who are Molecule.one’s competitors?
Genesis Molecular AI, Chemical Computing Group, X-37, Exscientia, and NuMedii are some of the 14 competitors of Molecule.one.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process